SecBot SecBot
8-K ·Filed Aug 28, 2026

OM

Outset Medical, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001193125-26-374323
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for the appointment of a new General Counsel in a subsequent filing; the departure is orderly and non-disruptive, so no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
OM ▼ -20.68% at T+20d
NEUTRAL call -20.68% · α vs SPY -20.31% · entry $3.82 → $3.03
Next anchor: T+60d in 28d
Latest observation: T+38 +42.74% FF3 residual α
Entry = T+0 close
Aug 28, 2026
via day close
T+1d
-4.71%
call -4.71% · α -4.03%
$3.64
settled 8w ago
T+5d
-9.16%
call -9.16% · α -9.02%
$3.47
settled 7w ago
T+20d
-20.68%
call -20.68% · α -20.31%
$3.03
settled 28d ago
T+60d
Pending
in 28d

Price Chart

Loading chart...

Executive Summary

Outset Medical disclosed that General Counsel John Brottem will depart on September 11, 2026, to pursue other professional opportunities. The filing explicitly states his departure is not due to any dispute with the company. This is a routine officer departure with no replacement named, but the role is non-C-suite and the exit is amicable, limiting material impact.

Key Facts

  • General Counsel John Brottem informed Outset Medical of his departure on August 27, 2026, effective September 11, 2026.
  • Departure is to pursue other professional opportunities and is not due to any dispute or disagreement with the company or its management.
  • No replacement has been named in the filing.

Financial Impact

No financial impact disclosed; departure of a non-CEO/CFO officer with amicable terms is unlikely to materially affect operations or financials.

Risk Factors

  • Potential temporary gap in legal leadership if a successor is not named promptly.
  • No material risk identified given the amicable nature of the departure.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
82% bullish (11 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-374323
Document: 0001193125-26-374323-index.html0001193125-26-374323
Document: 0001193125-26-374323.txt0001193125-26-374323
10 reports for OM
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for OM — sortable, filterable
TypeNow
Oct 21, 2026
4d ago
Press Release
NEUTRAL ★ 1/10
$4.17awaiting T+5—$4.08 (−2.16%)
Oct 6, 2026
19d ago
SC 13G/A
BULLISH ★ 5/10
$4.21 $3.84▼ −8.79%▼ −7.81%$4.08 (−3.09%)
Aug 28, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$3.82 $3.47▼ −9.16%▼ −9.02%$4.08 (+6.81%)
Aug 14, 2026
10w ago
144
BEARISH ★ 5/10
$4.51 $4.19▲ +7.10%▲ +5.90%$4.08 (+9.53%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$4.30 $4.02▼ −6.51%▼ −6.95%$4.08 (−5.12%)
May 19, 2026
22w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.38 $5.01▲ +14.38%▲ +12.58%$4.08 (−6.85%)
May 15, 2026
23w ago
144
NEUTRAL ★ 2/10
$3.72 $4.40▲ +18.28%▲ +16.66%$4.08 (+9.68%)
Apr 27, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$4.32 $4.33▲ +0.23%▼ −1.46%$4.08 (−5.56%)
Apr 24, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$4.41 $4.33▼ −1.81%▼ −2.21%$4.08 (−7.48%)
Apr 8, 2026
28w ago
Press Release
NEUTRAL ★ 3/10
$4.32 $4.40▲ +1.85%▼ −1.33%$4.08 (−5.56%)
Showing 10 of 10

US Market Status

Market Open — Closes in 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 28, 2026